Search results
Moderna Wins FDA Approval For Second-Ever Product; Why Its RSV Vaccine Could Dominate Pfizer, GSK
Investor's Business Daily· 6 hours agoBut it can be serious or even deadly in babies and older adults. Like rivals Pfizer and GSK — which...
FDA approves Moderna’s mRNA RSV vaccine for older adults
CNN via Yahoo News· 3 hours agoThe US Food and Drug Administration has approved another vaccine that can help protect older people...
NHS launches personalised mRNA cancer vaccines trial
Clinical Trials Arena via Yahoo Finance· 10 hours agovaccine trial. The company will present preliminary data, highlighting the potential of circulating tumour DNA in the early detection of colorectal...
Moderna's RSV vaccine for older adults approved
Axios· 1 hour agoWhy it matters: It's Moderna's second approved product, and company officials said it's the first mRNA vaccine approved for a disease other than COVID-19...
Pfizer says its its lung cancer drug Lorbrena could be a $1 billion blockbuster
Quartz· 7 hours agoPharma giant Pfizer said that its lung cancer drug Lorbrena could reach blockbuster status by 2030...
Pfizer (PFE) Up 1.8% Since Last Earnings Report: Can It Continue?
Zacks via Yahoo Finance· 6 hours agoSeagen drugs contributed $742 million to the top line in the first quarter. Revenues from Pfizer’s...
Scientists are testing mRNA vaccines to protect cows and people against bird flu - The Morning Sun
The Morning Sun· 17 hours agoThe bird flu outbreak in U.S. dairy cows is prompting development of new, next-generation mRNA ...
Pfizer sees lung cancer drug topping $1 billion in sales following impressive 5-year data
Reuters via Yahoo News· 9 hours agoPfizer said it expects its cancer drug Lorbrena to top $1 billion in annual sales by 2030 on the...
Thousands of Patients to Be Given World's First Cancer Vaccine
Futurism via Yahoo News· 1 hour agoThe United Kingdom's National Health Service (NHS) is fast-tracking patients for its game-changing...
Is Moderna Stock A Buy As The U.S. Government Mulls Its Bird Flu Vaccine?
Investor's Business Daily· 9 hours agoThe company noted that it achieved 48% market share for Covid vaccines in the U.S. during the fall...